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OBJECTIVES We investigated whether Adamantiades-Behcet’s disease (ABD) is related to impaired aortic
(Ao) elastic properties and left ventricular (LV) function.
BACKGROUND Adamantiades-Behcet’s disease is an inflammatory disorder characterized by vasculitis leading
to vascular complications and, rarely, myocarditis.
METHODS We studied 82 patients with ABD (age: 40  12 years) and 24 normal control subjects by
echocardiography. Abdominal Ao diameter (mm/m2) and Ao elastic indexes—namely, Ao strain
(%), distensibility (cm2  dyn1 106), stiffness index, and pressure strain modulus (Ep) (cm2
 dyn1 106)—were calculated from the echocardiographically derived thoracic Ao diameters
(mm/m2), and the measurement of pulse pressure obtained by cuff sphygmomanometry.
Isovolumic relaxation time (IVRT) (ms), deceleration time (DT) (ms), and flow propagation
velocity (FPV) (cm/s) were measured by Doppler echocardiography to assess diastolic LV
function. The duration of disease and presence of vascular complications were noted.
RESULTS Patients versus control subjects had increased Ao diameters (p 0.01), lower mean Ao strain
and distensibility (4 vs. 9 and 1.4 vs. 3.4, respectively, p  0.01), higher mean aortic stiffness
index and Ep (15.6 vs. 6 and 1.17 vs. 0.44, respectively, p  0.01), and impaired IVRT and
FPV (p  0.01). Aortic function indexes were related to the duration of disease (p  0.01)
and increased DT (p  0.01). Deceleration time 190 ms predicted vascular complications
with 80% sensitivity and 71% specificity (odds ratio 6.52 [confidence interval: 2.23 to 19.03]).
CONCLUSION Aortic elastic properties and diastolic LV function are impaired in patients with ABD and are
interrelated. The link between diastolic LV dysfunction and vascular complications suggests
the presence of a common pathophysiologic pathway and provides a possible marker of risk
for vascular disease. (J Am Coll Cardiol 2004;43:1075–81) © 2004 by the American
College of Cardiology Foundationl
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4damantiades-Behcet’s disease (ABD) is a chronic, relaps-
ng, inflammatory disease characterized by recurrent oral
nd genital ulceration, skin and ocular lesions (1,2). Ap-
roximately one-third of these patients develop vascular
anifestations, which include aneurysm formation, arterial
r venous occlusive disease, and neurological disorders due
o vasculitis of large and small vessels (3,4). Aortic disten-
ibility is an important determinant of left ventricular (LV)
unction and coronary blood flow (5–7). Additionally, aortic
istensibility has been related to increased cardiovascular
ortality in different populations (8,9) and increased risk of
ortic aneurysm rupture (10). However, the elastic proper-
ies of the aortic wall in patients with ABD have not been
nvestigated yet.
Cardiomyopathy (1,11,12) linked to vascular and intra-
ardiac thrombosis (11) has been frequently described in
atients with ABD. Coronary vasculitis or focal myocardial
nflammation (12) causing ischemia and fibrosis (11) may
From the *Department of Clinical Therapeutics, University of Athens, Alexandra
ospital, Athens, Greece; and †Rheumatology, Athens Medical Center, Athens,
reece.
Manuscript received July 19, 2003; revised manuscript received August 26, 2003,Iccepted October 6, 2003.ead to significant diastolic dysfunction of the LV (13) even
n the presence of normal systolic function. However, there
re conflicting data about the presence of LV diastolic
ysfunction in patients with ABD (14,15).
Two-dimensional guided mode echocardiography of the
ortic root combined with simultaneous sphygmomanomet-
ic measurements of the arterial pressure at the brachial
rtery has been used to assess aortic function indexes (9,16).
dditionally, two-dimensional and Doppler echocardiogra-
hy has extensively been used for assessing systolic and
iastolic LV function (13,17).
In the present study, we hypothesized that aortic elastic
roperties are impaired in patients with ABD, deteriorate as
isease progresses in time, and are linked to significant LV
iastolic dysfunction. We also investigated whether the
resence of vascular complications in these patients is linked
o a compromised cardiac function by means of two-
imensional and Doppler echocardiography.
ETHODS
tudy population. A total of 82 consecutive patients (age:
0  12 years; 54 males, 28 females) who fulfilled the
nternational Study Group (ISG) criteria for diagnosis of
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Aortic Function in Adamantiades-Behcet’s Disease March 17, 2004:1075–81ehcet disease (recurrent oral ulcerations and two of the
ollowing features: recurrent genital ulceration, eye lesions,
kin lesions, positive pathergy skin test [2]) were prospec-
ively studied as outpatients in the hospital’s vascular labo-
atory. Exclusion criteria were: 1) severe valve disease; 2)
trial fibrillation; and 3) the need for use of calcium channel
lockers and/or beta-blockers during the echocardiographic
tudy.
All patients were in functional class I of the New York
eart Association classification and had a history of recur-
Abbreviations and Acronyms
ABD  Adamantiades-Behcet’s disease
Ao  aorta
AoD  aortic diastolic diameter
AoS  aortic systolic diameter
DT  deceleration time
Ep  pressure strain modulus
FPV  flow propagation velocity
ISG  International Study Group
IVRT  isovolumic relaxation time
IVS  interventricular septum
LV  left ventricle/left ventricular
PP  pulse pressure
PW  posterior wall
Table 1. Clinical Characteristics of the Study P
Pati
Age (yrs) 40
Gender (M/F)
Cholesterol (mg/dl)
Triglycerides (mg/dl)
Hypertension (yes/no)
Parental CAD (yes/no)
Smoking (yes/no)
Diabetes (yes/no)
Clinical findings at examination (yes/no)
Oral ulceration
Genital ulceration
Arthritis
Skin lesions
Eye lesions
() Pathergy skin test
Vascular complications (yes/no)
Vascular thrombosis
Aneurysms
Stroke
Neurologic disease (yes/no)
Active disease* (yes/no)
Drugs†
Prednisolone
Azathioprine
Colchicine
Cyclosporin
Anti-hypertensive treatment‡
Statins
*2 diagnostic criteria of the International Study Group
‡Anti-hypertensive treatment included beta-blockers (n 3),
enzyme inhibitor (n  1) for patients and beta-blockers (n ABD  Adamantiades-Behcet’s disease; CAD  coronary arteent oral ulcerations; 28 had signs of active disease (2
iagnostic criteria of ISG for Behcet’s disease), and none
ad signs of active vascular disease during the study. All
atients had an erythrocyte sedimentation rate 50 mm at
he time of examination. All patients were receiving treat-
ent (Table 1). Because aortic and LV diastolic function
ndexes are associated with age and presence of atheroscle-
otic risk factors, patients with ABD were compared with
4 control subjects with similar age, gender, cholesterol, and
riglyceride plasma levels, as well as incidence of smoking,
ypertension, and diabetes mellitus. Subjects of the control
roup had no history of cardiovascular disease, normal
hysical examination, and normal resting electrocardio-
ram.
The study was approved by the local ethics committee,
nd patients gave informed written consent. Each patient
nderwent standard transthoracic two-dimensional and
oppler echocardiography. The duration of disease was
alculated from the time the patient fulfilled the ISG criteria
o the time of examination. History of vascular complica-
ions (vascular aneurysms, stroke, arterial or venous occlu-
ive disease) were also noted for each patient. Vascular
omplications were documented by conventional angiogra-
hy, digital subtraction angiography, ultrasonography, and
omputed tomography of the involved organ.
lation at the Time of Examination
With ABD
82)
Controls
(n  24) p Value
2 (17–73) 42  12 (22–75) NS
(65%) 14/10 (59%) NS
 45 223  46 NS
 50 113  45 NS
(15%) 4/20 (16%) NS
(8.5%) 2/22 (8%) NS
(51%) 11/14 (45%) NS
(3.6%) 1/23 (4%) NS
(57)
(31%)
(20%)
(31%)
(29%)
(38%)
(35%)
(26%)
(7%)
(7%)
(19%)
(35%)
(37%)
(17%)
(46%)
(11%)
(9%) 2/24 (9%) NS
(1.2%)
ehcet’s disease (1990); †medical treatment at inclusion;
ockers (n 2), diuretics (n 2), and angiotensin-converting
Ca blockers (n  1) for controls.opu
ents
(n 
 1
54/28
205
122
12/70
7/75
42/50
3/79
47/35
26/56
16/66
26/56
24/58
31/51
29/53
21/61
6/76
6/76
16/66
28/54
31/51
14/68
38/44
9/73
8/82
1/82
for B
Ca bl
1),
ry disease; () positive.
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March 17, 2004:1075–81 Aortic Function in Adamantiades-Behcet’s Diseasechocardiography and Doppler. All studies were per-
ormed using a Toshiba Sonolayer SSH 140A phased array
ltrasound system (Toshiba Corp., Japan). A 2.5-MHz
uplex transducer for combined cross-sectional imaging and
oppler echocardiography was used.
chocardiography of the aorta (Ao). The following pa-
ameters were measured from cross-sectional echocardio-
raphic images of the Ao:
. Thoracic Ao diameters (mm/m2) were measured 3 cm
above the aortic valve by two-dimensional guided
M-mode transthoracic echocardiography of the aortic
root at left parasternal long-axis view. Aortic systolic
diameter (AoS) was measured at the time of full opening
of the aortic valve, and diastolic (AoD) diameter at the
peak of the QRS complex at the simultaneous electro-
cardiogram recording. The following indexes of aortic
function were calculated: aortic strain (AS)  100 
(AoS  AoD)/AoD, aortic root distensibility  2 
(AoS  AoD)/(AoD  PP) (cm2  dyn(1)  10(6)),
aortic stiffness index  ln(SBP/DBP)  (AoS  AoD)/
AoD, and aortic pressure strain modulus (Ep)  PP/
[(AoS  AoD)/AoD] (cm2  dyn(1)  10(6)).
Pulse pressure (PP) was obtained simultaneously by cuff
phygmomanometry of the left brachial artery as systolic
SBP) minus diastolic blood pressure (DBP) (9,16).
Central aortic PP was also measured by radial artery
onometry and pulse wave analysis using the Spygmocor
pparatus (Sphygmocor, ATCOR Medical, Sydney, Aus-
ralia) (18). The above indexes of aortic function were then
alculated by inserting central aortic PP in the place of the
rachial-artery-derived PP in their formulas to correct for
ossible overestimation of the peripherally measured PP
19).
Central PP and the derived Ao distensibility, stiffness
ndex, and Ep were related to the corresponding left brachial
rtery PP and the derived Ao distensibility, stiffness index,
nd Ep (r  0.75, r  0.89, r  0.88, r  0.89, p  0.01,
espectively).
. Maximal Ao root diameter (mm/m2) was obtained from
the parasternal short-axis view of the aortic valve and left
atrium.
. Maximal abdominal Ao diameter (mm/m2) was mea-
sured from the subcostal window.
chocardiography of the LV. The following parameters
ere measured from cross-sectional echocardiographic im-
ges of the LV: 1) end-diastolic and end-systolic diameter
mm/m2); 2) fractional shortening (%); 3) LV outflow tract
iameter (mm); 4) left atrial dimensions (mm/m2); and 5)
nterventricular septal (IVS), posterior wall (PW) thickness
mm/m2), and LV mass using the formula proposed by the
enn Convention (20).
oppler echocardiography. Flow velocity profiles were
btained using color, pulsed, and continuous wave Doppler
rom apical projections, and measurements were made itilizing the software of the ultrasound equipment. Mitral
iastolic flow was obtained after the pulsed Doppler sample
olume was positioned perpendicular to the tips of the
itral valve leaflets and 7 to 11 cardiac cycles were recorded.
he Doppler cursor was then moved toward the LV outflow
osition, and the sample volume was placed approximately 1
m proximal to the aortic valve so that it would come in
ontact with the anterior mitral valve leaflet. Isovolumic
elaxation time (IVRT) (ms) was measured as the interval
etween the end of the aortic click artefact and the onset of
itral inflow waveform.
The following indexes were measured from the mitral
alve diastolic wave form: peak early (E) and atrial (A) flow
elocities (cm/s), E/A ratio, deceleration time (DT) (ms) of
he LV diastolic filling using standard methodology as
reviously described (13,21). Similarly, velocity time inte-
ral (cm) was measured by tracing the perimetry of the LV
utflow tract wave form, and the corresponding stroke
olume was calculated utilizing the equipment’s software.
eart rate (beats/min) was measured from simultaneous
lectrocardiogram recordings.
Color M-mode echocardiography was performed in the
pical four-chamber view with the cursor aligned parallel
ith the LV inflow. The longest column of flow from the
itral annulus to the apex of the LV was recorded. The
-mode cursor was placed at the center of the LV inflow.
low propagation velocity (FPV) was measured as the slope
f the first color aliasing velocity (45 cm/s) from mitral
nnulus in early diastole to 40 mm distally in the LV cavity
22). The ratio E/FPV was calculated, and patients were
ivided into those with 1.7 and those with 1.7 corre-
ponding to significantly elevated LV diastolic pressures
pulmonary capillary wedge pressure 12 mm Hg) (22).
tatistical analysis. All variables are expressed as mean 
D. Statistical analysis used SPSS (10.0 version) software.
npaired comparisons between patient subgroups or be-
ween patients and control subjects were performed using
he standard chi-square for categorical and the unpaired t
est for continuous data. Linear relations were checked
sing simple linear regression analysis. When a dependent
ariable was related to more than one independent variable,
ackward stepwise regression analysis model was used to
xclude interrelation between the examined variables. Inter-
ctions between various independent variables had been
xcluded using simple linear regression analysis before these
ariables were used in the stepwise regression analysis.
therosclerotic risk factors (smoking status, systolic and
iastolic blood pressure, cholesterol, triglyceride, and glu-
ose plasma levels) were forced in the regression analysis
odel, and each model was weighted for heart rate or age to
ake into account any possible relation with the examined
ariables. Differences between patients with vascular com-
lications, patients without, and control subjects were as-
essed using factorial analysis of variance. Logistic regres-
ion analysis was performed to examine the relation of the
ncidence of vascular complications with the measured
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Aortic Function in Adamantiades-Behcet’s Disease March 17, 2004:1075–81chocardiographic indexes. Receiver operator curve analysis
as used afterwards to determine the values of the echocar-
iographic indexes, which would best predict the incidence
f vascular complications. The odds ratio of the examined
ndex was then calculated using crosstabs analysis. A p 
.05 was considered to be the level of statistical significance.
ssessment of reproducibility. In 30 randomly selected
atients, measurements were repeated in a blinded manner
y a second observer. Differences between the two sets of
easurements were examined using the paired t test and
ere found not statistically significant.
ESULTS
atients versus control subjects. Patients and control
ubjects had similar age, gender, and atherosclerotic risk
actor distribution (Table 1). The mean duration of the
isease was 10  7.7 (range, 1 to 38) years.
ortic wall characteristics. Maximal thoracic and abdom-
nal aortic diameters were increased in patients compared
ith control subjects (p  0.05). Aortic strain and disten-
ibility were approximately twofold lower and Ep and aortic
tiffness index approximately threefold higher in patients
ompared with control subjects (p  0.01) (Table 2).
iastolic function. All patients had normal fraction short-
ning. Isovolumic relaxation time was prolonged, and FPV
as reduced in all patients compared with control subjects
p  0.01). Deceleration time was similar between patients
nd control subjects (p  NS) (Table 3). However, DT
alues were significantly higher in patients with vascular
omplications compared with control subjects (p  0.01)
Table 4). Moreover, the ratio E/FPV was significantly
able 2. Cross-Sectional Echocardiographic Indexes in All
atients Versus Controls
Echocardiographic
Indexes
ABD
(n  82)
Controls
(n  24) p Value
horacic Ao (mm/m2) 17.5  2.2 15  2.6 0.01
bdominal Ao (mm/m2) 10.3  1.7 8  1.6 0.01
o S (mm/m2) 15.3  1.8 15  2.6 NS
o D (mm/m2) 14.7  1.9 13.6  2.0 0.05
o strain (%) 4.4  3.5 9.9  5.6 0.01
o distensibility
(cm2  dyn1  106)
1.4  1.0 3.4  2.1 0.01
o stiffness index 15.6  10.9 6  3.6 0.01
p (cm2  dyn1  106) 1.17  0.83 0.44  0.25 0.01
P (mm Hg) 43  13 44  13 NS
V mass (g/m2) 97  20 93.7  17 NS
VS (mm/m2) 4.86  0.7 5  0.7 NS
W (mm/m2) 4.9  0.7 4.8  0.8 NS
DD (mm/m2) 24.5  2.5 23.6  2.5 NS
SD (mm/m2) 15  2.2 14.2  2.4 NS
S (%) 38  7 40  7 NS
A (mm/m2) 18  2.8 17.5  3.2 NS
BD  Adamantiades-Behcet’s disease; Ao  aorta; D  diastolic; EDD 
nd-diastolic diameter of left ventricle; Ep  aortic pressure strain modulus; ESD 
nd-systolic diameter of left ventricle; FS  fractional shortening; IVS  interven-
ricular septum; LA  left atrium dimensions; LV mass  left ventricular mass; PP
pulse pressure at brachial artery; PW  posterior wall; S  systolic.igher in patients than in control subjects. A total of 41 latients (50%) had an E/FPV 1.7, indicating elevated LV
iastolic pressures (p  0.05) (Table 3).
There was no association between the measured echocar-
iographic indexes and the presence of any of the diagnostic
riteria for Bechet’s disease. There were also no differences
n the indexes of aortic elastic properties or of LV diastolic
unction between patients treated with corticosteroids or
ther anti-inflammatory regimens (Table 1) and those
eceiving no anti-inflammatory medication at the time of
xamination.
elations with duration of disease. The duration of dis-
ase was related to low Ao strain and distensibility as well as
ncreased aortic stiffness index and Ep (r  0.30, r 
0.38, and r  0.26, r  0.22, respectively, weighted for
ge; p  0.01).
nterrelation of echocardiographic indexes. Low Ao dis-
ensibility, increased Ep, and aortic stiffness index were
ssociated with prolonged DT (r  0.26, r  0.24, and r
0.22, p  0.05, respectively). As expected (13,20,21), LV
ass, IVS, and PW thickness were related to increased
rachial PP (r  0.26, r  0.23, and r  0.26, p  0.05,
able 3. Doppler Indexes in All Patients Versus Controls
ABD
(n  82)
Controls
(n  24) p Value
R (beats/min) 76  12 77  17 NS
BP (mm Hg) 122  15 123  15 NS
BP (mm Hg) 80  9 79  8 NS
VRT (ms) 87  15 77  19 0.01
T (ms) 200  40 196  40.5 NS
PV (cm/s) 43  13 65  19 0.01
(cm/s) 70  16 74  16 NS
(cm/s) 62  15 69  15 NS
/A 1.12  0.35 1.15  0.37 NS
/FPV 1.75  0.60 1.14  0.44 0.01
TI (cm) 17.2  3.2 17.5  3.0 NS
V (ml) 54  16 56  14 NS
 A-wave peak velocity; ABD Adamantiades-Behcet’s disease; DBP diastolic
lood pressure; DT  deceleration time; E  E-wave peak velocity; E/A  E/A
atio; E/FPV  E/FPV ratio; FPV  flow propagation velocity; HR  heart rate;
VRT  isovolumic relaxation time; SBP  systolic blood pressure; SV  stroke
olume; VTI  velocity time integral.
able 4. Echocardiographic Indexes in Patients With Vascular
omplications Versus Those Without
Vascular Complications
p Value
Yes
(n  29)
No
(n  53)
R (beats/min) 77  12 77  13 NS
BP (mm Hg) 122  15 123  15 NS
BP (mm Hg) 80  9 79  8 NS
VRT (ms) 92  15 83  15 0.01
T (ms) 220  38 191  37 0.01
V mass (g/m2) 104  20 93  19 0.01
VS (mm/m2) 5.1  0.7 4.7  0.7 0.05
W (mm/m2) 5.2  0.7 4.8  0.7 0.01
o distensibility
(cm2  dyn1  106)
1.2  1.3 1.7  0.7 0.07
o  aortic; DBP  diastolic blood pressure; DT  deceleration time; HR  heart
ate; IVS interventricular septum; IVRT isovolumic relaxation time; LV mass
eft ventricular mass; PW  posterior wall; SBP  systolic blood pressure.
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March 17, 2004:1075–81 Aortic Function in Adamantiades-Behcet’s Diseaseespectively), maximal thoracic Ao diameters (r  0.26, r 
.23, and r 0.26, p 0.05, respectively), prolonged IVRT
r  0.25, r  0.31, and r  0.25, p  0.05, respectively),
nd DT (r  0.22, r  0.24, and r  0.23, p  0.05,
espectively). Age was also related to Doppler diastolic
ndexes (p  0.05) (21).
haracteristics of patients with vascular complications.
atients with vascular complications (n  29) were older
43  12 vs. 37  12 years, p  0.05), had higher LV mass
g/m2), IVS, PW thickness, IVRT, and DT than patients
ithout (Table 4). Logistic regression analysis showed that,
f the above indexes, only DT was significantly associated
ith the incidence of vascular complications independently
f age and atherosclerotic risk factors (exp [B]: 1.02 [con-
dence interval: 1.004 to 1.030], p 0.01). A DT190 ms
redicted the incidence of vascular complications with 80%
ensitivity and 71% specificity (receiver operator curve area:
5% [confidence interval: 60% to 87%]). The odds ratio of
patient with DT 190 ms to present vascular complica-
ions was calculated to be 6.52 (confidence interval: 2.23 to
9.03) (p  0.01). Interestingly, patients with vascular
omplications had a lower aortic distensibility than those
ithout (Table 4), though the difference was of borderline
tatistical significance (p  0.07).
ISCUSSION
o our knowledge, this is the first prospective study dem-
nstrating that aortic elastic properties and diameters are
everely impaired in patients with ABD compared with
ontrol subjects with similar atherosclerotic risk factor
rofiles. We have also shown that the extent of the changes
n aortic elastic properties is associated with the duration of
he disease and with LV diastolic dysfunction. Furthermore,
e demonstrated that a DT 190 ms indicates patients
ith vascular complications with an odds ratio of 6.52
confidence interval: 2.23 to 19.03) (p  0.01) and, thus,
ay provide a useful marker of increased risk for vascular
isease.
ortic elastic properties. Approximately one-third of pa-
ients with ABD develop vascular manifestations, which
nclude aneurysm formation, arterial or venous occlusive
isease, and stroke due to vasculitis of all size vessels (1,3,4).
n this study, we have shown that patients with ABD
evelop abnormal aortic elastic properties in addition to
ilation of thoracic and abdominal Ao compared with
ontrol subjects with similar age and atherosclerotic risk
actor distribution. Decreased aortic distensibility has been
elated to increased risk of aneurysm rupture (10). Thus, our
ndings provide a possible mechanism of aneurysm forma-
ion and rupture in patients with ABD (3,4).
Vasculitis of the vasa vasorum (1,23) causing fibrosis and
egradation of elastin within the aortic wall may explain the
resence of significant functional abnormalities of the as-
ending Ao and the dilation of the proximal and abdominal
o observed in our study. sIncreased circulating levels of tumor necrosis factor-
lpha, soluble interleukin 2 receptor, interleukin-1b,
nterleukin-6, and interleukin-8 have been reported in
atients with ABD (24). Cytokines promote production of
etalloproteinases (25,26) that degrade collagen and elastin
ontent of the aortic intima (27) and may, thus, contribute
o impaired function and dilation of the Ao (28). In the
resent study, we have also shown that the longer the
uration of the disease the greater the impairment of aortic
all elastic properties. During the course of the disease, the
onstant exposure of the aortic wall to increased circulating
ytokine levels (24) causes significant endothelial dysfunc-
ion (29). Reduced nitric oxide production by an injured
ortic endothelium may sustain cytokine-induced matrix
etalloproteinase release within the aortic layers over time
30). This mechanism may partly explain the relation of
bnormal aortic function indexes with the duration of the
isease observed in our study.
Patients treated with steroids had aortic elastic properties
imilar to those receiving other anti-inflammatory treatment
r no treatment at the time of examination. It is possible
hat treatment with steroids may have reduced aortic wall
nflammation and, thus, eliminated differences in aortic
lastic properties between those patients with more severe
isease in need of steroids compared with those with less
evere disease. However, this study was not designed to
ompare aortic wall characteristics before and after treat-
ent with steroids.
iastolic function. In the present study, we found that
oppler indexes of LV diastolic function were impaired in
atients with ABD compared with control subjects with
imilar atherosclerotic risk factors including hypertension.
urthermore, 50% of the patients had an E/FPV 1.7
uggesting significantly elevated LV diastolic pressures (22).
ur findings are in agreement with those of Gemici et al.
14) who also found impaired LV diastolic function associ-
ted with repolarization abnormalities in patients with
BD.
In our study, indexes of aortic function were associated
ith a prolonged DT suggesting a link between increased
ortic stiffness and impaired myocardial relaxation. Experi-
ental studies have shown that increased aortic stiffness
ugments LV afterload and impairs myocardial perfusion
6,7) causing significant LV diastolic dysfunction (13,21).
linical studies have also linked increased aortic stiffness to
vert diastolic heart failure (5). Thus, abnormal aortic elastic
roperties may represent one of the mechanisms of LV
iastolic dysfunction in our study population. Alternatively,
oronary vasculitis (1,3,12) or cytokine-induced myocardial
brosis (11,24,26,31) may have contributed to LV diastolic
ysfunction (13,21) in these patients.
iastolic indexes and vascular complications. In our
tudy, patients with vascular complications were older and
ad higher LV mass, wall thickness, and prolonged IVRT
nd DT compared with patients without. Studies have
hown that older age, increased LV mass, increased wall
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re interrelated (13,21). However, in a logistic regression
odel including age, of all measured echocardiographic
ndexes and atherogenic risk factors, only DT was associated
ith presence of vascular complications. Moreover, a DT
190 ms predicted the incidence of vascular complications
ith 80% sensitivity and 71% specificity (odds ratio, 6.52
confidence interval: 2.23 to 19.03]) and may, thus, provide
useful marker of risk for vascular disease.
The relationship between DT and vascular complications
uggests the presence of a common pathophysiologic path-
ay leading to thrombosis and myocardial and aortic wall
ysfunction. Interleukin-2, interleukin-6, interleukin-1b,
nd tumor necrosis factor-alpha have been reported elevated
n patients with ABD (24). Interleukin-2 has been related
ith reduced peak diastolic filling rate at radionuclide
entriculography in patients with cancer (31) as well as with
ascular thrombosis (32,33). Interleukin-6 has been found
o initiate coagulation (34) and to cause myocardial dys-
unction in experimental studies (35). Finally, the proco-
gulant cytokines interleukin-1b and tumor necrosis factor-
lpha (34) may induce metalloproteinase expression in the
ortic wall (25) and myocardium (26) and, thus, promote
brosis (26–28). Through these actions, cytokines may link
ascular thrombosis, stroke, or formation of arterial aneu-
ysms (3,4) to impairment of LV diastolic function. There-
ore, circulation of increased levels of inflammatory cyto-
ines may explain the link between DT and incidence of
ascular complications observed in our study.
tudy limitations. Pulse pressure was measured by cuff
phygmomanometry of the brachial artery and not invasively
n the ascending Ao. However, several reports have dem-
nstrated the excellent correlation of the non-invasively
alculated aortic function indexes with indexes derived from
ortography (9,16). Additionally, calculation of the same
ndexes using the central PP as assessed by radial artery
onometry and pulse wave analysis instead of the brachial
rtery PP (19) confirmed the results of our study. Another
otential limitation is that we have not excluded subclinical
oronary artery involvement. However, given the patients’
oung age, the lack of clinical findings, and the low
therosclerotic risk factor profile of our study population,
he likelihood for coronary artery disease is relatively low,
hough coronary involvement due to the Behcet syndrome
er se cannot be excluded.
onclusions. In this study, we have shown that patients
ith ABD present abnormal aortic elastic properties and
iameters in addition to impaired LV diastolic function
ompared with control subjects with similar atherosclerotic
isk factors. In these patients aortic stiffness was associated
ith the duration of the disease and with LV diastolic
ysfunction. Finally, a DT 190 ms was a marker of the
ncidence of vascular complications, suggesting the presence
f a common pathophysiologic pathway leading to throm-
osis and aortic and myocardial wall dysfunction.linical implications. Improvement of aortic elastic prop-
rties by medical treatment such as calcium channel blockers
36), angiotensin-converting enzyme inhibitors, or angio-
ensin type 1 receptor blockers (37) may be an important
herapeutic goal in patients with ABD in order to decrease
he risk of aneurysm formation (3) and rupture (4,10), to
mprove LV diastolic function (5), and, consequently, im-
rove prognosis (4,8,9) in these patients. Additionally,
easurement of DT by Doppler echocardiography may
rovide a simple, reproducible, and non-invasive technique
o identify patients at risk for vascular disease.
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